|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: CELOX LABORATORIES INC, 10QSB, 2000-07-14 |
Next: WATSON PHARMACEUTICALS INC, S-4, 2000-07-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> AUG-31-2000
<PERIOD-END> MAY-31-2000
<CASH> 127,147
<SECURITIES> 558,556
<RECEIVABLES> 14,072
<ALLOWANCES> 0
<INVENTORY> 53,932
<CURRENT-ASSETS> 776,174
<PP&E> 458,490
<DEPRECIATION> 346,131
<TOTAL-ASSETS> 941,262
<CURRENT-LIABILITIES> 116,241
<BONDS> 0
0
0
<COMMON> 36,832
<OTHER-SE> 788,189
<TOTAL-LIABILITY-AND-EQUITY> 941,262
<SALES> 127,835
<TOTAL-REVENUES> 127,835
<CGS> 57,674
<TOTAL-COSTS> 128,905
<OTHER-EXPENSES> 272,580
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 3,260
<INCOME-PRETAX> (253,517)
<INCOME-TAX> 0
<INCOME-CONTINUING> (253,517)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (253,517)
<EPS-BASIC> (0.08)
<EPS-DILUTED> (0.08)
</TABLE>
|
|